O	3	10	Fifteen
O	10	11	-
O	11	15	year
O	16	26	cumulative
O	27	36	incidence
O	37	39	of
B-Disease	40	43	age
I-Disease	43	44	-
I-Disease	44	51	related
I-Disease	52	59	macular
I-Disease	60	72	degeneration
O	72	73	:
O	74	77	the
O	78	84	Beaver
O	85	88	Dam
O	89	92	Eye
O	93	98	Study

O	100	107	Purpose
O	107	108	:
O	109	111	To
O	112	120	describe
O	121	124	the
O	125	127	15
O	127	128	-
O	128	132	year
O	133	143	cumulative
O	144	153	incidence
O	154	156	of
O	157	162	signs
O	163	165	of
B-Disease	166	171	early
I-Disease	172	175	and
I-Disease	176	180	late
I-Disease	181	184	age
I-Disease	184	185	-
I-Disease	185	192	related
I-Disease	193	200	macular
I-Disease	201	213	degeneration
O	214	215	(
B-Disease	215	218	AMD
O	218	219	)
O	219	220	.

O	222	228	Design
O	228	229	:
O	230	240	Population
O	240	241	-
O	241	246	based
O	247	253	cohort
O	254	259	study
O	259	260	.

O	262	274	Participants
O	274	275	:
O	276	278	We
O	279	287	included
O	288	292	3917
O	293	300	persons
O	300	301	,
B-Characteristic	302	304	43
I-Characteristic	305	307	to
I-Characteristic	308	310	86
I-Characteristic	311	316	years
I-Characteristic	317	319	of
I-Characteristic	320	323	age
O	324	326	at
O	327	330	the
O	331	335	time
O	336	338	of
O	339	340	a
O	341	349	baseline
O	350	361	examination
O	362	364	in
O	365	369	1988
O	370	377	through
O	378	382	1990
O	383	386	and
O	387	391	with
O	392	403	information
O	404	413	collected
O	414	416	in
O	417	423	follow
O	423	424	-
O	424	426	up
O	427	429	in
O	430	434	1993
O	435	442	through
O	443	447	1995
O	447	448	,
O	449	452	and
O	452	453	/
O	453	455	or
O	456	460	1998
O	461	468	through
O	469	473	2000
O	473	474	,
O	475	478	and
O	478	479	/
O	479	481	or
O	482	486	2003
O	487	494	through
O	495	499	2005
O	499	500	.

O	502	509	Methods
O	509	510	:
O	511	518	Grading
O	519	521	of
B-Diagnostic_tool	522	534	stereoscopic
I-Diagnostic_tool	535	541	fundus
I-Diagnostic_tool	542	553	photographs
O	554	559	using
O	560	563	the
B-Classification_system	564	573	Wisconsin
I-Classification_system	574	577	Age
I-Classification_system	577	578	-
I-Classification_system	578	585	Related
I-Classification_system	586	597	Maculopathy
I-Classification_system	598	605	Grading
I-Classification_system	606	612	System
O	612	613	.

O	615	619	Main
O	620	627	outcome
O	628	636	measures
O	636	637	:
O	638	648	Cumulative
O	649	658	incidence
O	659	661	of
B-Symptom	662	668	drusen
O	669	673	type
O	674	677	and
O	678	682	size
O	682	683	,
B-Symptom	684	694	pigmentary
I-Symptom	695	708	abnormalities
O	708	709	,
B-Symptom	710	720	geographic
I-Symptom	721	728	atrophy
O	728	729	,
O	730	733	and
B-Disease	734	743	exudative
I-Disease	744	747	AMD
O	748	758	accounting
O	759	762	for
O	763	772	competing
O	773	777	risk
O	778	780	of
O	781	786	death
O	786	787	.

O	789	796	Results
O	796	797	:
O	798	801	The
O	802	804	15
O	804	805	-
O	805	809	year
O	810	820	cumulative
O	821	830	incidence
O	831	834	was
O	835	837	14
O	837	838	.
O	838	839	3
O	839	840	%
O	841	844	for
B-Disease	845	850	early
I-Disease	851	854	AMD
O	855	856	(
O	856	859	the
O	860	868	presence
O	869	871	of
O	872	878	either
B-Symptom	879	883	soft
I-Symptom	884	894	indistinct
I-Symptom	895	901	drusen
O	902	904	or
O	905	908	the
O	909	917	presence
O	918	920	of
B-Symptom	921	931	pigmentary
I-Symptom	932	945	abnormalities
O	946	954	together
O	955	959	with
O	960	963	any
O	964	968	type
O	969	971	of
B-Symptom	972	978	drusen
O	978	979	)
O	980	983	and
O	984	985	3
O	985	986	.
O	986	987	1
O	987	988	%
O	989	992	for
B-Disease	993	997	late
I-Disease	998	1001	AMD
O	1002	1003	(
O	1003	1011	presence
O	1012	1014	of
B-Disease	1015	1024	exudative
I-Disease	1025	1028	AMD
O	1029	1031	or
B-Symptom	1032	1042	geographic
I-Symptom	1043	1050	atrophy
O	1050	1051	)
O	1051	1052	.

O	1053	1058	There
O	1059	1062	was
O	1063	1065	an
O	1066	1075	increased
O	1076	1085	incidence
O	1086	1088	of
B-Symptom	1089	1092	AMD
I-Symptom	1093	1100	lesions
O	1101	1105	with
B-Characteristic	1106	1109	age
O	1110	1111	(
O	1111	1112	P
O	1112	1113	<
O	1113	1114	0
O	1114	1115	.
O	1115	1117	05
O	1117	1118	)
O	1118	1119	.

O	1120	1131	Individuals
B-Characteristic	1132	1133	>
I-Characteristic	1134	1136	or
I-Characteristic	1137	1138	=
I-Characteristic	1139	1141	75
I-Characteristic	1142	1147	years
I-Characteristic	1148	1150	of
I-Characteristic	1151	1154	age
O	1155	1157	at
O	1158	1166	baseline
O	1167	1170	had
O	1171	1184	significantly
O	1185	1186	(
O	1186	1187	P
O	1187	1188	<
O	1188	1189	0
O	1189	1190	.
O	1190	1192	01
O	1192	1193	)
O	1194	1200	higher
O	1201	1203	15
O	1203	1204	-
O	1204	1208	year
O	1209	1219	incidences
O	1220	1222	of
O	1223	1226	the
O	1227	1236	following
O	1237	1252	characteristics
O	1253	1257	than
O	1258	1264	people
B-Characteristic	1265	1267	43
I-Characteristic	1268	1270	to
I-Characteristic	1271	1273	54
I-Characteristic	1274	1279	years
I-Characteristic	1280	1282	of
I-Characteristic	1283	1286	age
O	1286	1287	:
B-Symptom	1288	1294	larger
I-Symptom	1295	1301	drusen
O	1302	1303	(
B-Dimension	1303	1306	125
I-Dimension	1307	1310	mum
I-Dimension	1311	1313	in
I-Dimension	1314	1322	diameter
O	1322	1323	,
O	1324	1326	24
O	1326	1327	.
O	1327	1328	1
O	1328	1329	%
O	1330	1332	vs
O	1333	1335	10
O	1335	1336	.
O	1336	1337	6
O	1337	1338	%
O	1338	1339	)
O	1339	1340	,
B-Symptom	1341	1345	soft
I-Symptom	1346	1356	indistinct
I-Symptom	1357	1363	drusen
O	1364	1365	(
O	1365	1367	18
O	1367	1368	.
O	1368	1369	7
O	1369	1370	%
O	1371	1373	vs
O	1374	1375	6
O	1375	1376	.
O	1376	1377	5
O	1377	1378	%
O	1378	1379	)
O	1379	1380	,
B-Symptom	1381	1388	retinal
I-Symptom	1389	1399	pigmentary
I-Symptom	1400	1413	abnormalities
O	1414	1415	(
O	1415	1417	20
O	1417	1418	.
O	1418	1419	2
O	1419	1420	%
O	1421	1423	vs
O	1424	1425	3
O	1425	1426	.
O	1426	1427	7
O	1427	1428	%
O	1428	1429	)
O	1429	1430	,
B-Disease	1431	1440	exudative
I-Disease	1441	1448	macular
I-Disease	1449	1461	degeneration
O	1462	1463	(
O	1463	1464	4
O	1464	1465	.
O	1465	1466	4
O	1466	1467	%
O	1468	1470	vs
O	1471	1472	0
O	1472	1473	.
O	1473	1474	4
O	1474	1475	%
O	1475	1476	)
O	1476	1477	,
O	1478	1481	and
B-Symptom	1482	1486	pure
I-Symptom	1487	1497	geographic
I-Symptom	1498	1505	atrophy
O	1506	1507	(
O	1507	1508	3
O	1508	1509	.
O	1509	1510	2
O	1510	1511	%
O	1512	1514	vs
O	1515	1516	0
O	1516	1517	%
O	1517	1518	)
O	1518	1519	.

O	1520	1531	Controlling
O	1532	1535	for
B-Characteristic	1536	1539	age
O	1539	1540	,
O	1541	1549	compared
O	1550	1554	with
O	1555	1560	those
O	1561	1565	with
O	1566	1571	small
O	1572	1579	numbers
O	1580	1582	of
O	1583	1587	only
B-Symptom	1588	1593	small
I-Symptom	1594	1598	hard
I-Symptom	1599	1605	drusen
I-Symptom	1606	1607	(
I-Symptom	1607	1608	1
I-Symptom	1608	1609	-
I-Symptom	1609	1610	2
I-Symptom	1610	1611	)
O	1611	1612	,
O	1613	1618	those
O	1619	1623	with
O	1624	1629	large
O	1630	1637	numbers
O	1638	1640	of
O	1641	1645	only
B-Symptom	1646	1650	hard
I-Symptom	1651	1657	drusen
I-Symptom	1658	1659	(
I-Symptom	1659	1660	>
I-Symptom	1661	1663	or
I-Symptom	1664	1665	=
I-Symptom	1665	1666	8
I-Symptom	1666	1667	)
O	1668	1671	had
O	1672	1674	an
O	1675	1684	increased
O	1685	1687	15
O	1687	1688	-
O	1688	1692	year
O	1693	1696	age
O	1696	1697	-
O	1697	1705	adjusted
O	1706	1715	incidence
O	1716	1718	of
O	1719	1723	both
B-Symptom	1724	1728	soft
I-Symptom	1729	1739	indistinct
I-Symptom	1740	1746	drusen
O	1747	1748	(
O	1748	1750	16
O	1750	1751	.
O	1751	1752	3
O	1752	1753	%
O	1754	1756	vs
O	1757	1758	4
O	1758	1759	.
O	1759	1760	7
O	1760	1761	%
O	1761	1762	)
O	1763	1766	and
B-Symptom	1767	1777	pigmentary
I-Symptom	1778	1791	abnormalities
O	1792	1793	(
O	1793	1795	10
O	1795	1796	.
O	1796	1797	6
O	1797	1798	%
O	1799	1801	vs
O	1802	1803	2
O	1803	1804	.
O	1804	1805	7
O	1805	1806	%
O	1806	1807	)
O	1807	1808	.

B-Anatomy	1809	1813	Eyes
O	1814	1818	with
B-Symptom	1819	1823	soft
I-Symptom	1824	1834	indistinct
I-Symptom	1835	1841	drusen
O	1842	1844	or
B-Symptom	1845	1855	pigmentary
I-Symptom	1856	1869	abnormalities
O	1870	1872	at
O	1873	1881	baseline
O	1882	1886	were
O	1887	1891	more
O	1892	1898	likely
O	1899	1901	to
O	1902	1909	develop
B-Disease	1910	1914	late
I-Disease	1915	1918	AMD
O	1919	1921	at
O	1922	1928	follow
O	1928	1929	-
O	1929	1931	up
O	1932	1936	than
B-Anatomy	1937	1941	eyes
O	1942	1949	without
O	1950	1955	these
O	1956	1963	lesions
O	1964	1965	(
O	1965	1967	17
O	1967	1968	.
O	1968	1969	8
O	1969	1970	%
O	1971	1973	vs
O	1974	1975	1
O	1975	1976	.
O	1976	1977	2
O	1977	1978	%
O	1979	1982	and
O	1983	1985	12
O	1985	1986	.
O	1986	1987	9
O	1987	1988	%
O	1989	1991	vs
O	1992	1993	1
O	1993	1994	.
O	1994	1995	7
O	1995	1996	%
O	1996	1997	,
O	1998	2010	respectively
O	2010	2011	)
O	2011	2012	.

O	2014	2025	Conclusions
O	2025	2026	:
O	2027	2029	We
O	2030	2038	document
O	2039	2042	the
O	2043	2047	long
O	2047	2048	-
O	2048	2052	term
O	2053	2062	incidence
O	2063	2065	of
O	2066	2071	signs
O	2072	2074	of
B-Disease	2075	2078	AMD
O	2079	2082	and
O	2083	2084	a
O	2085	2094	continuum
O	2095	2099	from
B-Symptom	2100	2105	small
I-Symptom	2106	2110	hard
I-Symptom	2111	2117	drusen
O	2118	2120	to
B-Disease	2121	2125	late
I-Disease	2126	2129	AMD
O	2130	2132	in
B-Characteristic	2133	2138	older
I-Characteristic	2139	2146	persons
O	2147	2149	in
O	2150	2153	the
O	2154	2164	population
O	2164	2165	.

O	2166	2169	The
O	2170	2172	15
O	2172	2173	-
O	2173	2177	year
O	2178	2188	cumulative
O	2189	2198	incidence
O	2199	2201	of
B-Disease	2202	2206	late
I-Disease	2207	2210	AMD
O	2211	2213	in
O	2214	2220	people
B-Characteristic	2221	2222	>
I-Characteristic	2223	2225	or
I-Characteristic	2226	2227	=
I-Characteristic	2228	2230	75
I-Characteristic	2231	2236	years
I-Characteristic	2237	2239	of
I-Characteristic	2240	2243	age
O	2244	2245	(
O	2245	2246	8
O	2246	2247	%
O	2247	2248	)
O	2249	2258	indicates
O	2259	2260	a
O	2261	2267	public
O	2268	2274	health
O	2275	2282	problem
O	2283	2285	of
O	2286	2297	significant
O	2298	2309	proportions
O	2310	2317	because
O	2318	2321	the
B-Characteristic	2322	2328	United
I-Characteristic	2329	2335	States
I-Characteristic	2336	2346	population
O	2347	2351	this
B-Characteristic	2352	2355	age
O	2356	2358	is
O	2359	2367	expected
O	2368	2370	to
O	2371	2379	increase
O	2380	2382	by
O	2383	2385	54
O	2385	2386	%
O	2387	2394	between
O	2395	2399	2005
O	2400	2403	and
O	2404	2408	2025
O	2408	2409	.
